- Home
- CUE vs LTBR Comparison
CUE vs LTBR Comparison
Compare CUE & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUE | LTBR |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | United States | United States |
| Employees | N/A | 13 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.0M | 191.7M |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CUE | LTBR |
|---|---|---|
| Price | $21.97 | $5.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $88.00 | N/A |
| AVG Volume (30 Days) | 153.2K | ★ 646.7K |
| Earning Date | 11-11-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,466,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 195.75 | N/A |
| 52 Week Low | $0.17 | $4.87 |
| 52 Week High | $45.50 | $27.30 |
Technical Indicators
Market Signals| Indicator | CUE | LTBR |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 41.93 |
| Support Level | $17.06 | $4.87 |
| Resistance Level | $33.95 | $7.04 |
| Average True Range (ATR) | 2.33 | 0.31 |
| MACD | 0.45 | 0.06 |
| Stochastic Oscillator | 41.30 | 46.49 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, engaged in research and development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.